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Formation of the death-inducing signaling complex
(DISC) initiates extrinsic apoptosis. Caspase-8 and
its regulator cFLIP control death signaling by binding
to death-receptor-bound FADD. By elucidating the
function of the caspase-8 homolog, caspase-10, we
discover that caspase-10 negatively regulates cas-
pase-8-mediated cell death. Significantly, we reveal
that caspase-10 reduces DISC association and acti-
vation of caspase-8. Furthermore, we extend our co-
operative/hierarchical binding model of caspase-8/
cFLIP and show that caspase-10 does not compete
with caspase-8 for binding to FADD. Utilizing cas-
pase-8-knockout cells, we demonstrate that cas-
pase-8 is required upstream of both cFLIP and
caspase-10 and that DISC formation critically de-
pends on the scaffold function of caspase-8. We
establish that caspase-10 rewires DISC signaling to
NF-kB activation/cell survival and demonstrate that
the catalytic activity of caspase-10, and caspase-8,
is redundant in gene induction. Thus, our data are
consistent with a model in which both caspase-10
and cFLIP coordinately regulate CD95L-mediated
signaling for death or survival.INTRODUCTION
The apoptotic signaling cascade can be initiated by extrinsic or
intrinsic stimuli. Extracellular death ligands, such as the cluster
of differentiation 95 ligand (CD95L) (also known as FasL/
Apo-1L) or TRAIL, bind to their respective receptors, mostThis is an open access article undlikely to preformed receptor trimers (Chan et al., 2000). Upon
ligand binding, the adaptor protein FADD is recruited via its
death domain to the receptor. The initiator caspase-8 then binds
via its two death effector domains (DED) to the DED of FADD
(Sprick et al., 2000). Proteins recruited upon receptor activation
form a membrane-bound so-called death-inducing signaling
complex (DISC) (Kischkel et al., 1995). After formation of the
DISC, the large and small catalytic subunits of the caspase-8
homodimer are cleaved and activate downstream effector cas-
pases (Hughes et al., 2009; Oberst et al., 2010). Additionally,
active caspase-8 cleaves substrates, such as Bid, thereby con-
necting the extrinsic and intrinsic apoptotic pathway (Li et al.,
1998). DISC-mediated caspase-8 cleavage is regulated by
cFLIP, a DED containing caspase-like protein without protease
activity (Irmler et al., 1997). Like caspase-8, cFLIP binds via its
DEDs to the DISC and was shown to block caspase-8-mediated
cell death (Leverkus et al., 2000; Siegmund et al., 2002; Wachter
et al., 2004), although the long isoform of cFLIP (cFLIPL) can
also activate caspase-8 by mechanisms that are only now
becoming clear (Boatright et al., 2004; Dohrman et al., 2005b;
Hughes et al., 2016; Micheau et al., 2002; Yu et al., 2009).
The DISC is a complex synergy of recruited proteins, and
recent studies have shown that DISC stoichiometry is different
than prior models suggested, such that a single FADD molecule
is able to recruit a multitude of caspase-8 molecules to the DISC
via DED chain assembly (Dickens et al., 2012; Schleich et al.,
2012). Death ligand-induced DISC formation is known to activate
other signaling cascades beyond caspase-8. When caspase ac-
tivity is blocked, death ligands can trigger necroptotic cell death,
depending on the kinase activity of RIPK1 and RIPK3 (Feoktis-
tova et al., 2011, 2012; Geserick et al., 2009; Tenev et al.,
2011). In addition, DISC formation leads to NF-kB activation
and cytokine gene induction (Choi et al., 2001; Farley et al.,
2008; Park et al., 2003; Schmidt et al., 2015). Death ligand-medi-
ated cytokine production occurs, in part, analogous to tumorCell Reports 19, 785–797, April 25, 2017 ª 2017 The Authors. 785
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
necrosis factor (TNF) signaling; RIPK1 is required for the activa-
tion of NF-kB by the degradation of IkBa (Peter et al., 2007). Of
note, an interaction of RIPK1 with the DISC or soluble cas-
pase-8 after receptor stimulation can primarily be detected
whenever caspase activity is blocked (Cullen et al., 2013; Harper
et al., 2001). However, it remains to be elucidated how RIPK1
is activated upon DISC formation. Interestingly, cFLIP is known
to inhibit DISC-mediated gene induction, indicative of a critical
but complex role of DISC-associated caspase-8 and cFLIP for
regulation of cell death/gene induction (Kavuri et al., 2011;
Wachter et al., 2004).
Caspase-10, a close homolog of caspase-8, is a highly
conserved caspase throughout evolution, although absent in ro-
dents (Eckhart et al., 2008; Sakamaki et al., 2015). It is recruited
to and processed in the DISC (Kischkel et al., 2001; Sprick et al.,
2002; Wang et al., 2001), and both caspase-8 and -10 share
overlapping substrate specificities (Fischer et al., 2006). It is
currently assumed that caspase-8 and caspase-10 have redun-
dant functions in cell death signaling, but the ability of caspase-
10 to substitute for caspase-8 has remained controversial. Due
to the lack of caspase-10 in rodents, its function cannot be easily
studied in vivo. Published experimental approaches to study its
gene function have been mainly limited to overexpression
studies that putatively derail the stoichiometry of DISC signaling
(M€uhlethaler-Mottet et al., 2011).
Here, we have identified an unanticipated role for caspase-10
in switching the CD95L-mediated response from caspase-8-
induced cell death to activation of NF-kB and cell survival. We
found that caspase-10 impedes caspase-8 activation within
the CD95 DISC and that this occurs independently of cFLIP.
Moreover, we demonstrate that caspase-10 promotes DISC-
mediated gene induction and, independent of its catalytic activ-
ity, facilitates NF-kB signaling. Remarkably, we discover an
indispensable scaffold function for caspase-8 in DISC formation.
Thus, we show that, independent of its enzymatic activity, cas-
pase-8 must bind to FADD to allow further recruitment of
caspase-10 and/or cFLIP. Taken together, our data reveal that
caspase-10 is a negative regulator of caspase-8-mediated cell
death and instead supports CD95-induced gene induction.
RESULTS
Caspase-10 Inhibits CD95L-Induced Cell Death
To analyze the function of caspase-10 in CD95L-induced cell
death, we performed small interfering RNA (siRNA)-mediated
knockdown of caspase-10 in HeLa cells (Figure 1A). Whereas
depletion of caspase-8 protected cells from CD95L-induced
death, knockdown of caspase-10 reproducibly enhanced
CD95-induced cell death. Under these conditions, cell death
was caspase-8 mediated, as combined knockdown of cas-
pase-8 and -10 fully protected cells from death induction.
Knockdown of caspase-10 using four different siRNAs
confirmed the inhibitory function of caspase-10 (Figure 1B).
Moreover, HeLa cells expressing a doxycycline-induced cas-
pase-10 short hairpin RNA (shRNA) were also significantly
more sensitive to CD95L killing following knockdown of cas-
pase-10 as measured by different assays (Figures 1C–1E and
S1). The heightened sensitivity to CD95L was not due to an786 Cell Reports 19, 785–797, April 25, 2017altered surface expression pattern of CD95 by knockdown of
caspase-10 (data not shown). Next, we investigated other cell
lines (diverse melanoma lines [SK-Mel, IGR, WK, and MC],
B cell and T cell lymphoma [BJAB and Jurkat], and spontane-
ously transformed keratinocytes [HaCaT]) for the impact of cas-
pase-10 on CD95L-induced cell death. As observed in HeLa
cells, SK-Mel melanoma showed a significant sensitivity to
CD95L after the depletion of caspase-10 (Figure 1F). In sum-
mary, we found that caspase-10 protects from CD95L-induced
cell death in three out of eight cell lines examined.
Caspase-10 and cFLIP Independently Inhibit Caspase-8-
Mediated Cell Death
Interestingly, all cell lines unaffected by the knockdown of cas-
pase-10 showed a higher expression level of caspase-10 (exam-
ples shown for HaCaT/MC versus HeLa/SK-Mel in Figures 2A
and 2B). Remarkably, protein levels after successful knockdown
of caspase-10 in HaCaT or MC cells were comparable to endog-
enous levels present in HeLa or SK-Mel (Figure 2A). This differen-
tial stoichiometry of caspase-10 was also reflected in the DISC
(Figure S2). We initially hypothesized that the low levels of cas-
pase-10 remaining in these ‘‘high expressors’’ was sufficient to
inhibit CD95L-induced cell death. However, a closer look at
the expression levels of caspase-10 and cFLIP in HaCaT cells
showed a reciprocal counter-regulation of cFLIP after inducible
knockdown of caspase-10 (Figures 2C and 2D). Moreover,
changes in cFLIP expression were also reflected in the DISC
with an increased level of cleaved cFLIP p43 bound to the recep-
tor (Figure 2C). In contrast, caspase-8 or FADD levels in the DISC
were unchanged (Figure 2C). These data revealed a close rela-
tionship between cFLIP and caspase-10 for inhibition of cell
death. To corroborate this assumption, we next combined the
knockdown of caspase-10 and cFLIP in HaCaT cells. As shown
in Figure 2D, combination of caspase-10 and cFLIP knockdown
increased the sensitivity of cells to CD95L (Figures 2D and S3A,
dark red columns). As cFLIP expression in HaCaT is very low
(Figure 2A), we aimed to extend the data to cell lines with higher
cFLIP levels. We thus performed siRNA-mediated knockdown
of caspase-10 and cFLIP in HeLa cells. Depletion of either cas-
pase-10 (Figure 2E, light red columns) or cFLIP (Figure 2E, black
columns) led to a dramatic increase in CD95-induced cell death.
Notably, similar to our data in HaCaT cells, combined knock-
down of caspase-10 and cFLIP further increased sensitization
to CD95L when compared to caspase-10/cFLIP knockdown
alone (Figures 2E and S3B, dark red columns). Taken together,
our data showed that caspase-10 is a negative regulator of
CD95L-induced cell death, independent of cFLIP. However, at
least in HaCaT cells, loss of caspase-10 is compensated by
increased expression of cFLIP.
Caspase-10 Impedes DISC-Mediated Caspase-8
Activation
Next, we examined whether caspase-10 modulates assembly of
the DISC by characterizing DISC formation in the presence or
absence of caspase-10. Upon caspase-10 depletion in HeLa
cells, we observed an enrichment of full-length and p43/41 cas-
pase-8 cleavage fragments in the DISC (Figure 3A). Quantifica-
tion of the ratio of caspase-8 (full length; p43/41) relative to
Figure 1. Caspase-10 Impairs CD95L-
Induced Cell Death
(A) HeLa cells were transfected with caspase-10
(siC10), caspase-8 (siC8), the combination of both,
or control siRNA (siCTRL). After 72 hr, triplicates
were preincubated with 10 mM zVAD-fmk (zVAD)
or 50 mM Necrostatin-1 (Nec) or the combination
of both for 1 hr followed by stimulation of 1 U/mL
CD95L-Fc for 16–20 hr. Cell viability was analyzed
by crystal violet (CV) staining. Knockdown effi-
ciency was controlled by western blotting (WB).
(B) HeLa cells were transfected with four different
caspase-10 (siC10) or control (siCTRL) siRNAs.
After 72 hr, corresponding triplicates were pre-
incubated with 10 mM zVAD for 1 hr followed by
stimulation of 1 U/mL CD95L-Fc for 16–20 hr. Cell
viability was analyzed by CV staining. Knockdown
efficiency was controlled by WB.
(C–E) HeLa cells inducibly expressing a shRNA
against caspase-10 (shC10) or control shRNA
(shCTRL) were treated with 0.5 mg/mL doxycycline
for 72 hr. (C) Cells were stimulated in triplicates for
the indicated time points with 2 U/mL CD95L-Fc.
Cell survival was analyzed as described above.
Knockdown efficiency was controlled by WB.
(D) Cells were stimulated with the indicated
concentrations of CD95L-Fc for 3 hr. Apoptotic
cells (annexin V positive and CellMetrix negative)
were measured by analyzing the externalization
of phosphatidylserine and plasma membrane
integrity by Pacific Blue Annexin V plus CellMetrix
Green Live/Dead Stain using flow cytometry.
A representative experiment is shown in Fig-
ure S1A. (E) Cells were stimulated with the indi-
cated CD95L-Fc concentrations for 7 hr. DNA
degradation was quantified by flow cytometry
using propidium iodide (PI) staining for sub
G1 populations. A representative experiment is
shown in Figure S1B.
(F) SK-Mel cells were transfected with caspase-10
(siC10) and control siRNA (siCTRL). Seventy-two
hours later, corresponding triplicates were pre-
treated with 10 mM zVAD for 1 hr followed by
stimulation with the indicated concentrations of
CD95L-Fc for 4 hr. Cell viability was analyzed by
CV staining. Knockdown efficiency was controlled
by WB.
Each graph/diagram represents mean values ±
SEM of at least three independent experiments.
Significance levels (p values) were measured by
Student’s t test (C–F) or two-way ANOVA test
(A and B; *p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001).
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Figure 2. Both cFLIP and Caspase-10 Block
Caspase-8-Mediated Cell Death
(A) Different cell lines were transfected with
siC10 or siCTRL. After 72 hr, knockdown effi-
ciency and proteins involved in DISC signaling
were analyzed by WB. Cell lines with high
expression of caspase-10 (HaCaT and MC) were
compared to low-expressing cell lines (HeLa and
SK-Mel).
(B) HaCaT and MC cells were treated with siC10
and siCTRL as described in (A). Triplicates were
pre-treated with 10 mM zVAD-fmk (zVAD) for 1 hr
followed by stimulation of 0.1 (HaCaT) and 2.5
(MC) U/mL CD95L-Fc for 16–20 hr (HaCaT) or 4 hr
(MC). Cell viability was analyzed by CV staining.
(C) shC10 or shCTRL expression was induced in
HaCaT cells by the addition of 0.5 mg/mL doxy-
cycline (Doxy) for 72 hr. Cells were stimulated with
1 U/mL CD95L-Fc for the indicated time points.
CD95 was immunoprecipitated from cell lysates
(TL), and co-precipitated proteins were analyzed
by WB. The asterisk marks a non-specific band.
(D) HaCaT cells were transfected with siC10,
sicFLIP, the combination of both, or siCTRL. After
48 hr, cells were pre-treated in triplicates with
10 mM zVAD for 1 hr and further stimulated for 4 hr
with 0.5 U/mL CD95L-Fc. Cell viability was as-
sayed using CV staining. Knockdown efficiency
was controlled by WB.
(E) HeLa cells were treated with siRNA as
described in (D), stimulated with the indicated
concentrations of CD95L-Fc, and analyzed for
their cell viability by CV staining. Knockdown
efficiency was controlled by WB.
Each diagram represents mean values ± SEM
of three independent experiments. Significance
levels (p values) weremeasured by Student’s t test
(B) or two-way ANOVA test (D and E; *p < 0.05;
**p < 0.01; ***p < 0.001; ****p < 0.0001; n.s., not
significant).FADDwithin theDISC confirmed an enhancement of DISC-asso-
ciated caspase-8 in the absence of caspase-10 (Figure 3B). In
contrast, the recruitment of cFLIP to the DISC was unaffected
(Figure 3B). Taken together, these findings support our conclu-
sion of a negative regulatory function for caspase-10 in death
signaling.
To analyze the proposed inhibitory function of caspase-10 in
more detail, we reconstituted the CD95 DISC in a cell-free sys-
tem using recombinant protein as previously described (Hughes
et al., 2009). Strikingly, we observed a concentration-dependent
inhibition of caspase-8 by caspase-10 (Figure 3C). Caspase-10
blocked processing of caspase-8 in the DISC and reduced
DISC-associated IETDase activity (Figure 3C). Furthermore,
our data confirm the ability of cFLIPL to activate caspase-8, as
well as the co-operative and hierarchical binding model of cas-788 Cell Reports 19, 785–797, April 25, 2017pase-8 and cFLIP (Hughes et al., 2016).
As shown in Figure 3C, recruitment of
cFLIPL to the complex is enhanced by
the presence of caspase-8. Intriguingly,
our data suggest a similar model of co-operative binding can now be linked to caspase-10. In the
absence of caspase-8, recruitment of caspase-10 to the DISC
is inefficient and, importantly, IETDase activity is absent
(Figure 3C). Taken together, our data demonstrate that cas-
pase-10 impedes caspase-8 processing, thereby reducing
DISC-associated caspase activity.
Caspase-8 Is Indispensable for the Assembly of the
CD95 DISC
To further study the co-operative binding of caspase-10 and
caspase-8 to the CD95 DISC and to explore whether cas-
pase-10 can substitute for caspase-8 in the native DISC,
we next generated caspase-8 knockout HeLa cells using
CRISPR/Cas9-mediated recombination. Two independent C8
CRISPR cell clones (C8 CRISPR), generated with two different
Figure 3. Caspase-10 Impairs Recruitment
and Activation of Caspase-8 in the DISC
(A) shCTRL or shC10 expression was induced by
0.5 mg/mL doxycycline in HeLa cells. After 72 hr,
cells were incubated for the indicated time points
with 2 U/mL CD95L-Fc. CD95 was immunopre-
cipitated from cell lysates (TL), and DISC-associ-
ated proteins were analyzed for DISC recruitment
by western blotting. The asterisks mark non-spe-
cific bands.
(B) Relative density of co-precipitated caspase-8
(full-length a/b and p43/41) and cFLIP p43 from
the CD95L kinetic shown in (A) was quantified in
respect to co-precipitated FADD and normalized
to shCTRL cells. Shown are mean values ± SEM
of three independent experiments. Significance
levels (p values) weremeasured by Student’s t test
(*p < 0.05; **p < 0.01).
(C) A functional CD95 DISC was assembled using
GST-CD95 intracellular domain (10 mg), recombi-
nant FADD (r-FADD) (5 mg), and 35S-labeled re-
combinant procaspase-8b (r-C8b) (85 mL) at 20C
for 16 hr in the absence or presence of recombi-
nant cFLIPL or increasing amounts of recombinant
procaspase-10a (C10a) (25–225 mL; indicated as
13, 33, 63, and 93). Beads and supernatants
were analyzed by SDS-PAGE and autoradiog-
raphy for 35S C8b and immunoblotted for FADD,
caspase-10, and cFLIP. Beads were additionally
assayed for caspase-8 activity (IETDase). Control
CD95 DISCs contained C10a or cFLIPL in the
absence of r-C8b. Data shown are representative
of three independent experiments. Asterisks mark
non-specific bands.guide RNAs (gRNAs) (Figure S4), were fully protected from
CD95L-induced death irrespective of the expression of cas-
pase-10 (Figure 4A). Intriguingly, C8 CRISPR cells also had
repressed cFLIP/caspase-10 levels as compared to parental
cells (Figures 4A and 4B, right panels). We next studied DISC
composition in the absence of caspase-8. In line with our re-
constituted DISC model, we observed that, despite effective
precipitation of CD95, the native DISC isolated from C8
CRISPR cells completely lacked cFLIP and caspase-10Ce(Figure 4B), and strikingly, only weak
levels of FADD were detected upon pro-
longed exposure of the blots. To exclude
clonal artifacts during generation of C8
CRISPR cells, we next reconstituted
caspase-8a and its respective active
site mutant (ASM) in C8 CRISPR cells
by inducible overexpression. When
these cells were analyzed for CD95L-
induced cell death, re-expression of cas-
pase-8, but not its ASM, conferred
sensitivity to CD95L-induced cell death,
despite a lower overall expression level
of the enzymatically active caspase-8a
(Figure 5A). Intriguingly, reconstitution
of caspase-8 protein restored therecruitment of cFLIP, caspase-10, and, importantly, FADD in
the DISC independent of the enzymatic activity of caspase-8
(Figure 5B). The caspase-8 ASM, however, fully protected
cleavage of caspase-8, caspase-10, or cFLIP, indicative of
the critical importance of caspase-8 enzymatic activity for in-
duction of cell death, but not initial recruitment of DED proteins.
Thus, our data reveal a central role for caspase-8 in formation
of the CD95 DISC and places caspase-8 upstream of both
cFLIP and caspase-10 in DISC signaling.ll Reports 19, 785–797, April 25, 2017 789
Figure 4. CD95 DISC Formation Requires
Caspase-8
(A) Parental and caspase-8-deficient (C8 CRISPR)
HeLa cells were treated for 72 hr with 0.5 mg/mL
doxycycline to induce the expression of either
control or caspase-10 shRNA. Cells were pre-
treated for 1 hr with 10 mM zVAD-fmk (zVAD)
followed by stimulation with the indicated con-
centrations of CD95L-Fc for 4 hr. Knockdown
efficiency of caspase-10 aswell as the knockout of
caspase-8 was controlled byWB. Cell viability was
analyzed in triplicates by crystal violet staining.
Shown are mean values ± SEM of three indepen-
dent experiments. Significance levels (p values)
were measured by two-way ANOVA test (*p <
0.05; **p < 0.01; ****p < 0.0001).
(B) CD95 DISC formation was analyzed in parental
and HeLa C8 CRISPR cells. CD95 was immuno-
precipitated from cell lysates (TL) after stimulation
with 2 U/mL CD95L-Fc for the indicated time
points. DISC-associated proteins were analyzed
by WB. Asterisks mark non-specific bands.Caspase-10 Promotes CD95L-Mediated NF-kB
Activation and Gene Induction
We thus far explored caspase-10 for its impact on DISC-medi-
ated cell death signaling. However, the function of the enzymatic
activity of caspase-10 remains unclear. We reasoned that
another function of caspase-10 might be related to the known
gene-inductive properties exerted by CD95 stimulation (Cullen
et al., 2013; Wallach et al., 1999). Moreover, it is well known
that zVAD strongly supports DISC-mediated gene induction
(Harper et al., 2001), and we have also previously reported that
QVD allows for TRAIL-induced gene activation (Kavuri et al.,
2011). However, when we compared zVAD and QVD for their
impact on CD95L-mediated interleukin-8 (IL-8) mRNA expres-
sion, IL-8 induction was unaffected by QVD (Figure S5A).
Furthermore, we observed that QVD was, firstly, inefficient
in blocking CD95L-induced cell death compared to zVAD790 Cell Reports 19, 785–797, April 25, 2017(Figure S5B) and, secondly, only partially
blocked processing of caspase-8 after
DISC stimulation (Figure S5C). Therefore,
we characterized the role of caspase-10
in death-receptor-mediated gene induc-
tion in HeLa cells by microarray analysis
in the presence of zVAD to achieve
maximal gene expression. We observed
that caspase-10 knockdown did not
affect the subset of genes induced upon
CD95L stimulation; rather it impacts on
the amplitude of induction of a variety of
NF-kB-induced target genes (Table S1).
Of note, we identified a number of
CD95L-induced genes to be deregulated
by knockdown of caspase-10 (Table S1,
light orange), with three genes exhibit-
ing >25% repression of gene induction
(Table S1, dark orange). Thus, we aimed
to verify selected genes in more detailand importantly demonstrated that loss of caspase-10 signifi-
cantly repressed IL-8 secretion after CD95L stimulation (Fig-
ure 6A). Furthermore, we analyzed the impact of caspase-10
on six CD95L-induced genes via real-time qPCR and observed
that caspase-10 knockdown significantly reduced CD95L-medi-
ated gene induction by 20%–50% in all targets examined (Fig-
ure 6B). As described for TNF-R-signaling, CD95L-induced
gene induction is driven by multiple protein kinases, including
the IKK complex, JNK, or p38 mitogen-activated protein (MAP)
kinases (Cullen et al., 2013; Wallach et al., 1999). To study
the impact of caspase-10 on these kinases, we generated cas-
pase-10 knockout (C10 CRISPR) HeLa cells, which confirmed
the heightened sensitivity to CD95L stimulation observed by
knockdown approaches (Figure S6A). Whereas we failed to
detect obvious differences in the phosphorylation status of
JNK or p38MAP kinase (MAPK) under conditions with or without
Figure 5. Caspase-8 Scaffold Function
Is Indispensable for DISC Recruitment of
DED Proteins
Caspase-8a (C8a) and its respective active site
mutant (C8a ASM) were reconstituted in caspase-
8-deficient HeLa (C8 CRISPR) cells.
(A) Parental and HeLa C8 CRISPR cells either
overexpressing the empty vector (CTRL), C8a, or
C8a ASM were treated with 10 nM 4-hydroxy-
tamoxifen (4-HT) for 6 hr to induce the expres-
sion of the respective constructs. Cells were
pre-treated with 10 mM zVAD-fmk (zVAD) for 1 hr
followed by stimulation with 5 U/mL CD95L-Fc for
3 hr. Cell viability was analyzed in triplicates by
crystal violet staining. Shown are mean values ±
SEM of three independent experiments. Signifi-
cance levels (p values) were measured by two-
way ANOVA test (****p < 0.0001). Expression of
C8a and C8a ASM were analyzed by western
blotting.
(B) As described in (A), C8a was reconstituted
in HeLa C8 CRISPR cells for 6 hr by 4-HT. Cell
lines were stimulated with 2 U/mL CD95L-Fc for
the indicated time points. CD95 was immuno-
precipitated from cell lysates (TL) and analyzed
for DISC-associated proteins. Asterisks mark
non-specific bands.caspase-10 expression (data not shown), CD95L-mediated IkBa
degradation/phosphorylation was inhibited in C10 CRISPR cells
(Figures 6C and S6B).
Corroborating our findings of an upstream role for caspase-8
in DISC formation, CD95L-induced cytokine gene induction
was fully absent in C8 CRISPR cells. In contrast, reconstitution
with caspase-8a/ASM allowed for IL-8 mRNA induction, albeit
to a lesser extent than parental cells (Figure 6D). To accommo-
date for differing expression levels between re-expressed wild-
type and ASM caspase-8, we examined IL-8 mRNA induction
relative to caspase-8 expression in parental cells (Figures 6D
and S6C). Moreover, C10 CRISPR cells confirmed our previous
data obtained by inducible knockdown. In the absence of
caspase-10, IL-8 mRNA induction was reduced following
CD95L stimulation (Figure 6E), whereas reconstitution with
wild-type or ASM caspase-10a increased IL-8 induction in
these cells (Figures 6E and S6D). Our experiments using
reconstituted caspase-8a ASM, as well as caspase-10a ASM,
clearly showed that caspase-mediated cytokine induction oc-
curs independently of catalytic activity (Figures 6D and 6E).CeThus, caspase-10 and 8 promote DISC-
mediated gene induction, revealing
an intricate balance of gene-inducing/
death-promoting abilities of these two
DISC-associated tandem DED proteins.
DISCUSSION
To date, studies about DISC signaling
have focused on the function of
caspase-8 and its regulator cFLIP. Incontrast, the role of caspase-10 is more controversial and less
understood. The interplay of the tandem DED proteins
caspase-8 and -10 and cFLIP is complex; in our study, downre-
gulation of one of these proteins frequently resulted in a rapid
counter-regulation of at least one of the other tandem DED
proteins. For example, loss of caspase-8 leads to a downregula-
tion of cFLIP (Figures 4 and 5), HaCaT cells counter-regulate
the loss of caspase-10 by upregulation of cFLIP (Figure 2), and
caspase-8-deficient Jurkat cells were shown to downregulate
caspase-10 (Sprick et al., 2002). These phenomena occurred
remarkably quickly during cell culture, thus showing how closely
these proteins are inter-linked and critical for cell survival.
Notably, caspase-10/8 and cFLIP are located on the same
genetic locus (2q33-q34), and co-regulated genes tend to
be clustered in the same genetic neighborhood (Michalak,
2008). Taken together, our findings underscore the necessity
to simultaneously study all tandem DED proteins.
We focused our attention on the role of caspase-10 and strik-
ingly found that this caspase is a negative regulator of DISC-
mediated apoptosis (Figure 1). Thus far, caspase-10 wasll Reports 19, 785–797, April 25, 2017 791
Figure 6. Caspase-10 Promotes CD95L-
Mediated Gene Induction
(A and B) HeLa cells expressing shC10 or shCTRL
were treated for 72 hr with 0.5 mg/mL doxycycline.
(A) Duplicate wells were stimulated in media con-
taining 0.5% FCS with the indicated concentra-
tions of CD95L-Fc for 24 hr. Supernatants were
analyzed for secreted interleukin-8 (IL-8) by ELISA.
Cell viability was assayed using crystal violet
staining. (B) HeLa ± shC10 cells were pre-starved
for 4 hr in media containing 0.5% FCS followed by
treatment with 10 mM zVAD-fmk (zVAD) for 1 hr.
Cells were stimulated with 0.1 U/mL CD95L-Fc for
3 hr. RNA was isolated, reverse transcribed to
cDNA, and mRNA expression levels of IL-8, IL-6,
CCL2, EGR1, CXCL3, and TNF were analyzed by
real-time qPCR.
(C) Parental and caspase-10-deficient (C10
CRISPR) HeLa cells were starved and pre-treated
with zVAD as described in (B). Cells were stimu-
lated with CD95L-Fc (0.0025, 0.005, 0.01, 0.025,
0.05, or 0.1 U/mL) for 3 hr. IkBa phosphorylation
as well as degradation and caspase-10 knockout
were analyzed by western blotting. Asterisks mark
non-specific bands.
(D) Parental and caspase-8-deficient (C8 CRISPR)
HeLa cells were treated with 10 nM 4-HT for 6 hr
in media containing 0.5% FCS to induce the
expression of either control plasmid or cas-
pase-8a (expression of caspase-8a ASM was
achieved in the absence of induction via 4-HT).
Cells were stimulated with zVAD and CD95L-Fc
as described in (B) and analyzed for IL-8
mRNA expression by real-time qPCR. Caspase-8
expression was quantified after reconstitution
and compared to parental HeLa cells as indi-
cated in the western blots. Relative IL-8 mRNA
induction has been calculated with respect to
caspase-8 expression.
(E) Parental, C10 CRISPR, and reconstituted
caspase-10a/ASM HeLa cells were treated as
described in (D) (expression of wild-type cas-
pase-10 was achieved in the absence of induc-
tion via 4-HT). Cells were stimulated with zVAD
and CD95L-Fc as described in (B) and IL-8
mRNA expression analyzed. Relative caspase-10
expression and IL-8 induction has been calculated
as described in (D) (raw data for D and E are
shown in Figures S6C and S6D).
Each graph/diagram represents mean values ±
SEM of three independent experiments. Signifi-
cance levels (p values) were measured by
Student’s t test (*p < 0.05; **p < 0.01; ***p < 0.001).reported to be a pro-apoptotic initiator caspase, similar to cas-
pase-8 (Engels et al., 2005; Fischer et al., 2006). Importantly,
our data exclude a pro-apoptotic function of caspase-10, inde-
pendent of the cell line or the experimental setting used
(siRNA-/shRNA-mediated knockdown or gene knockout).
Significantly, our reconstituted DISC approach clearly demon-
strates the negative impact of caspase-10 on caspase-8 in a792 Cell Reports 19, 785–797, April 25, 2017cell-free system (Figure 3). In line with our data and a more com-
plex role of caspase-10, a recent study has proposed a pro-
survival function of endogenous caspase-10, as it was shown
to inhibit autophagic cell death in multiple myeloma cell lines
(Lamy et al., 2013).
When we studied the impact of caspase-10 mechanistically,
caspase-10 was shown to impair recruitment/processing of
Figure 7. A Dual Role for Caspase-10 in
DISC Signaling
In this model, FADD binding to the CD95 receptor
initiates formation of the DISC. Caspase-8 binding
is then required to stabilize the FADD receptor
association and enable subsequent recruitment
of caspase-10. The presence or absence of
caspase-10 defines the amplitude of the cell
death response. In the absence of caspase-10,
caspase-8 DED chain assembly strongly acti-
vates downstream effector caspases to induce
apoptosis. Simultaneously, caspase-8 promotes
RIPK1 activation by mechanisms that to date have
not been elucidated. Next, NF-kB dimerizes and
localizes to the nucleus to induce cytokine gene
expression. In the presence of caspase-10, DISC-
mediated caspase-8 activity and subsequent
cell death are reduced. Moreover, caspase-10,
together with caspase-8, favors RIPK1 activation
and NF-kB-mediated gene induction, indepen-
dent of caspase-10/caspase-8 catalytic activity.
Thus, taken together, caspase-10 switches the
cell death response in favor of cell survival and
cytokine gene expression.caspase-8 in the DISC (Figure 3). Previous mass spectrometry
analysis of the native CD95- and TRAIL DISC demonstrated
that FADD is clearly sub-stoichiometric as compared to cas-
pase-8, leading to a paradigm-changing model of DED chain
elongation that is mainly driven by caspase-8 (Dickens et al.,
2012; Schleich et al., 2012). In marked contrast, the ratio of cas-
pase-8 to caspase-10 or cFLIP protein levels, respectively, are
much lower and until recently have not been examined in detail.
A recent report has suggested that short DED proteins regulate
caspase-8 activation in DED chains (Schleich et al., 2016). More-
over, we have recently shown that overexpression of cFLIPS
disrupts caspase-8 chain assembly (Hughes et al., 2016). Based
on the data we present here, we hypothesize that caspase-10
may also disrupt caspase-8 chain elongation (Figure 7), but
this will require further investigation. In line with this assumption,
overall levels of DISC-bound caspase-8 were reduced in the
presence of caspase-10 (Figure 3). Furthermore, IETDase
activity of the reconstituted DISC was repressed by cas-
pase-10 (Figure 3). Interestingly, DISC-associated caspase-10
was unable to activate IETDase in the absence of caspase-8
(Figure 3), despite reports that in vitro dimerized caspase-10
catalytic subunits harbor IETDase activity (Wachmann et al.,
2010). However, this finding suggests another possibility for
caspase-10 in terms of inhibiting cell death. Caspase-10 and
caspase-8 could potentially form heterodimers with reduced
or absent activity. In this regard, heterodimerization between
caspase-8/10 and cFLIPL has been reported (Boatright et al.,
2004; Yu et al., 2009), but it is highly controversial whether the
resulting heterodimer has pro- or anti-apoptotic functions
(reviewed in van Raam and Salvesen, 2012).
In line with our very recent report on cFLIP (Hughes et al.,
2016), our studies demonstrate that caspase-8 is located up-
stream of both caspase-10 and cFLIP in the cell death pathway
with critical relevance for DISC formation (Figures 4 and 5). Ourre-expression studies with wild-type/ASM caspase-8 in C8
CRISPR cells restored recruitment of caspase-10, cFLIP, and
importantly FADD to the DISC, independent of the catalytic ac-
tivity of caspase-8 (Figure 5). Moreover, we show that FADD as-
sociation within the DISC is stabilized by caspase-8 binding
(Figures 4 and 5). Thus, our data demonstrate that a scaffold
function of caspase-8 is both necessary and critical for DISC
formation. However, in contrast to its homolog caspase-8,
caspase-10 is not essential for DISC signaling. Altogether, our
studies reveal that caspase-10 and cFLIP negatively regulate
cell death signaling within the DISC but that this occurs down-
stream of caspase-8 recruitment. This finding is in contrast to
previous reports made in caspase-8-deficient Jurkat cell lines,
in which caspase-10 was recruited to the DISC in the absence
of caspase-8 (Sprick et al., 2002). Importantly, we observed a
weakly expressed truncated form of caspase-8 in caspase-8-
deficient Jurkat cells (data not shown). Thus, because low levels
of caspase-8 can restore caspase-10 and cFLIP recruitment to
the DISC (Figure 5), these findings likely explain the previous re-
sults with caspase-8-deficient Jurkat cells (Sprick et al., 2002).
Therefore, some of the collected knowledge about apoptotic
and gene-inductive signaling gained from caspase-8-deficient
Jurkat cells has to be critically re-evaluated.
In addition to the apoptosis-inducing machinery, DISC-medi-
ated gene induction is an important signaling pathway that is
activated concomitant to apoptotic cell death (Peter et al.,
2007) but is most frequently observed under conditions indepen-
dent of apoptotic caspase-8 activation, e.g., in the presence of
broad spectrum caspase inhibitors (Harper et al., 2001; Kavuri
et al., 2011; Leverkus et al., 2003). Importantly, we observed
that QVD failed to support DISC-mediated gene induction and
that it is inefficient in blocking CD95L-induced caspase-8
cleavage and cell death (Figure S5). Very recently, it has been
shown that QVD, in contrast to zVAD, is a weak inhibitor of theCell Reports 19, 785–797, April 25, 2017 793
caspase-8/cFLIPL heterodimer, whereas both almost equally
block the caspase-8 homodimer (Brumatti et al., 2016). Studies
on the function of cFLIPL in the activation of NF-kB upon DISC
formation are contradictory. It has been reported that the cFLIP
p43 fragment promotes the recruitment of TRAF2 and RIPK1 to
the caspase-8/cFLIP heterodimer, resulting in more efficient
activation of NF-kB (Dohrman et al., 2005a). In contrast, several
studies reported an inhibitory function of cFLIPL in DISC-
mediated gene induction (Kavuri et al., 2011; Kreuz et al.,
2004). This clearly needs to be further examined but puts
the caspase-8/cFLIP heterodimer in the spotlight for DISC-
induced NF-kB activation. Strikingly, our data now show
that caspase-10 promotes DISC-mediated cytokine expression
by enhancing IkBa degradation/phosphorylation (Figure 6;
Table S1). Whereas the molecular mechanisms of DISC-medi-
ated gene induction are largely unknown, our studies show
that the scaffold function of caspase-8 is essential for DISC
formation as well as NF-kB activation (Figure 6); moreover, the
catalytic activity of caspase-8 and -10 is redundant for NF-kB
activation and subsequent cytokine induction. However, it still
remains to be elucidated how and where caspase-8 and -10
activate RIPK1 to initiate the phosphorylation of IkBa.
Our data for CD95L demonstrate that caspase-10 shifts the
apoptotic cell death response following DISC formation to the
activation of NF-kB and cell survival (Figure 7), both beneficial
features for tumor cells. Thus, caspase-10may have tumorigenic
properties. Chronic inflammatory gene expression favors tumor
formation and progression (Chai et al., 2015), and CD95
signaling has been shown in several studies to favor tumor
growth and invasiveness (Barnhart et al., 2004; Chen et al.,
2010). Thus, our data hint at the possibility of modulating cas-
pase-10 expression as a therapeutic oncological target; repres-
sion of caspase-10 reduces cytokine expression (Figure 6) and
favors apoptosis (Figure 1), potentially resulting in impaired
tumor growth. Whether DISC-mediated gene induction is
responsible for CD95 dependency of cancer cells remains unan-
swered. However, we have previously demonstrated that pri-
mary keratinocytes activate NF-kB upon stimulation of the TRAIL
DISC, and they are 5-fold less sensitive to death-ligand-induced
apoptosis than transformed keratinocytes (Kavuri et al., 2011;
Leverkus et al., 2000). Thus, gene induction is potentially much
more relevant in DISC signaling than currently assumed.
Here, we reveal the elusive, and in part controversial, role of
caspase-10 in DISC signaling. Our discovery of caspase-10 as
a negative regulator of cell death and a facilitator of gene induc-
tion separates the function of cFLIP and caspase-10 in the DISC.
Crucially, we demonstrate that caspase-8 binding via FADD to
the receptor is an indispensable initiating step in DISC formation
and NF-kB activation. Moreover, our data clearly delineate that
caspase-10 is not an initiator of DISC-induced cell death
signaling as previously believed. Instead, caspase-10 and
caspase-8 scaffold function promote DISC-mediated gene
induction, revealing an intricate balance of gene-inducing and
death-protecting abilities of the different DISC-associated tan-
dem DED proteins (Figure 7). These findings change our current
understanding of extrinsic apoptotic signaling and open new
possibilities in terms of signaling via other caspase-8 and -10
and cFLIP-containing complexes, such as the ripoptosome or794 Cell Reports 19, 785–797, April 25, 2017TNF complex (Feoktistova et al., 2011; Micheau and Tschopp,
2003; Tenev et al., 2011).
EXPERIMENTAL PROCEDURES
Supplemental Experimental Procedures contain details of materials, anti-
bodies, siRNA transfection, cytotoxicity assays, western blot analysis, IL-8
ELISA, and primer sequences used for real-time qPCR.
Generation of Stable Cell Lines
To generate stable cell lines that inducibly overexpress caspase-8a/10a and
their respective active site mutants by addition of 4-hydroxytamoxifen, cells
were transduced with a pF GEV16 Super PGKHygro as previously described
(Diessenbacher et al., 2008). Viral vectors inducibly expressing a shRNA
against caspase-10 (V3THS_394573) or the respective control shRNA (TRIPZ
inducible lentiviral non-silencing shRNA control) via the pTRIPZ lentiviral
shRNAmir system by addition of doxycycline were purchased fromGEHealth-
care and used for production of lentiviral particles using a second-generation
packing system. In brief, HEK293T cells were transfected with 3 mg pMD2.G,
7.5 mg pSPax2, and 3 mg pcDNA3.1/p35 of lentiviral packaging vectors
together with the transfer vector pF 5 3 UAS W SV40 Puro, which expresses
caspase-8 in a Gal4-dependent fashion. Caspase-8a/ASM was subcloned
from pcDNA3.1 (Hughes et al., 2009) and caspase-10a/ASM from pEF6/V5-
His-TOPO into lentiviral vector system using standard cloning procedures
and verified by sequencing. Supernatants were harvested 24 and 48 hr
post-transfection and filtered (0.45 mm filter; GE Healthcare). Viral particles
were added to the cells with 5 mg/mL polybrene, and cells were spin infected
for 1.5 hr at 30C. Antibiotic-resistant stable cell lines were selected in
300 mg/mL hygromycin and/or 1 mg/mL puromycin for 3–7 days.
Caspase-8/10-deficient HeLa cells were generated using the CRISPR/
Cas9 system. HeLa cells were transiently transfected using Lipofectamine
LTX Reagent with PLUS Reagent (Thermo Fisher Scientific) according
to manufacturer’s recommendations. HeLa cells were cotransfected with
the pMA-T vector (carrier of the cassette-U6-gRNA(casp8)-TTTTT; Life Tech-
nologies) and hCas9-pcDNA3.3-TOPO (Addgene) to generate caspase-8
knockout cells. Caspase-10 knockout cells were generated by the use of the
pSpCas9(BB)-2A-GFP (PX458) plasmid (Addgene). gRNA insertion was per-
formed as previously described (Ran et al., 2013). gRNA sequences were de-
signed using the open access software provided at http://crispr.mit.edu/ to
target the 50 end of the gene and thus all isoforms of either caspase-8 or 10.
The gRNA sequences were as follows:
Casp8-1: GCCTGGACTACATTCCGCAA
Casp8-2: GCTCTTCCGAATTAATAGAC
Casp10: GGGGGTCCAAGATGTGGAGA
Two days post-transfection, cells were sorted with a BD FACSAria I
(BD Biosciences) and single clones isolated and analyzed for successful
caspase-8/10 knockout.
Immunoprecipitation of the CD95 Receptor
For the precipitation of DISC-associated proteins, 1.5 3 107 cells were used.
The procedure of CD95 precipitation was performed as described previously
(Cullen et al., 2013). Equal amounts of precipitates were analyzed by western
blotting as described above.
Reconstitution of the CD95 DISC
Complete reconstitutions were carried out essentially as described previously
(Hughes et al., 2009). Recombinant procaspase-10a was produced by in vitro
transcription/translation (TNT T7-coupled reticulocyte lysate system; Promega)
usingpEF6/V5-His-TOPOvector containing caspase-10aor its respectiveASM.
Real-Time qPCR
RNA isolation, cDNA synthesis, primer design, and real-time qPCR as well as
data analysis were performed as described previously (Feoktistova et al.,
2011). Data shown have been normalized toGAPDH and have been confirmed
by normalization to 18S.
Microarray Analysis
HeLa cells were seeded in 6-well plates, and respective shRNAexpressionwas
inducedby theadditionof 0.5mg/mLdoxycycline for 72hr. In three independent
experiments, cells were prestarved for 4 hr with media containing 0.5% fetal
calf serum (FCS) followed by zVAD-fmk treatment (10 mM) for 1 hr. Cells were
then stimulated with 0.1 U/mL CD95L for 3 hr. Total RNA from stimulated or
control cells was isolated and tested by capillary electrophoresis on an Agilent
2100 bioanalyzer (Agilent Technologies) to confirm RNA quality. Gene expres-
sion profiling was performed using arrays of human Hugene-2_0-st-type from
Affymetrix according to manufacturer’s instructions. Bioinformatic evaluations
were done as previously described (Czymai et al., 2010). Significant regulated
genes (adjusted p values [false discovery rate (FDR)] < 0.05) were considered
by a fold change >2 compared to unstimulated control cells.
Statistics
Statistical analysis was carried out using GraphPad Prism. Statistical signifi-
cance (p values) was analyzed using either paired Student’s t test (two-tailed)
or two-way ANOVA, including Dunnett corrections for multiple comparisons,
as indicated in the figure legends.
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